Makhzoumi Mohamad
Insider CIK 1630226 · MRKR 10% owner · SVRA 10% owner · AVEO 10% owner · ARDX 10% owner · GNCA 10% owner · RGLS 10% owner · SYBX Director, 10% owner · TRVI 10% owner · MTCR 10% owner · RPHM 10% owner · BHG Director, 10% owner · INZY 10% owner · KRRO 10% owner · NITE 10% owner · EAR 10% owner · AKUS 10% owner · DM 10% owner · MIRM 10% owner · MBX 10% owner · SGP 10% owner · HOOD Director, 10% owner · ACLX 10% owner · NKTK 10% owner · BGRY 10% owner · IONQ 10% owner · GLUE 10% owner · SNTI 10% owner
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| SYBX SYNLOGIC, INC. | P Buy deriv | 2026-07-27 | 2026-08-14 | 2,640,845 | — | $0 | 2,640,845 | SEC↗ |
| SYBX SYNLOGIC, INC. | H Expire deriv | 2026-07-27 | 2026-08-14 | 2,640,845 | — | $0 | 0 | SEC↗ |
| SYBX SYNLOGIC, INC. | P Buy deriv | 2026-07-27 | 2026-08-14 | 2,640,845 | — | — | 2,640,845 | SEC↗ |
| SYBX SYNLOGIC, INC. | H Expire deriv | 2026-07-27 | 2026-08-14 | 2,640,845 | — | — | 0 | SEC↗ |
| KRRO Korro Bio, Inc. | P Buy deriv | 2026-03-10 | 2026-03-12 | 242,945 | $11.11 | $2.70M | 242,945 | SEC↗ |
| KRRO Korro Bio, Inc. | P Buy | 2026-03-10 | 2026-03-12 | 207,100 | $11.11 | $2.30M | 1,297,893 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 1,619,240 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 402,273 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 954,990 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 737,962 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 1,370,168 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion deriv | 2026-02-09 | 2026-02-11 | 1,370,168 | — | $0 | 0 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 1,370,168 | — | $0 | 4,359,576 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 1,370,168 | — | $0 | 2,989,408 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 1,619,240 | — | $0 | 1,619,240 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 402,273 | — | $0 | 1,357,263 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 954,990 | — | $0 | 954,990 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | P Buy | 2026-02-09 | 2026-02-11 | 937,500 | $16.00 | $15.00M | 6,035,038 | SEC↗ |
| SGP SpyGlass Pharma, Inc. | C Conversion | 2026-02-09 | 2026-02-11 | 737,962 | — | $0 | 5,097,538 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2025-10-02 | 2025-10-06 | 186,128 | — | $0 | 186,128 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-10-02 | 2025-10-06 | 186,128 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer deriv | 2025-10-02 | 2025-10-06 | 75,000 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer deriv | 2025-10-02 | 2025-10-06 | 37,700 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-10-02 | 2025-10-06 | 1,656,789 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-10-02 | 2025-10-06 | 607,536 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2025-10-02 | 2025-10-06 | 124,085 | — | $0 | 124,085 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-10-02 | 2025-10-06 | 124,085 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer deriv | 2025-10-02 | 2025-10-06 | 125,000 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer deriv | 2025-10-02 | 2025-10-06 | 100,000 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-10-02 | 2025-10-06 | 189,195 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2025-10-02 | 2025-10-06 | 434,297 | — | $0 | 434,297 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-10-02 | 2025-10-06 | 434,297 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-10-02 | 2025-10-06 | 189,195 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2025-10-02 | 2025-10-06 | 372,255 | — | $0 | 372,255 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-10-02 | 2025-10-06 | 189,195 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-10-02 | 2025-10-06 | 372,255 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | F Tax w/h | 2025-10-02 | 2025-10-06 | 280 | $6.75 | $1.9K | 1,526,937 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-10-02 | 2025-10-06 | 434,297 | $0.01 | $4.3K | 1,961,234 | SEC↗ |
| NEUE NeueHealth, Inc. | F Tax w/h | 2025-10-02 | 2025-10-06 | 643 | $6.75 | $4.3K | 1,960,591 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer | 2025-10-02 | 2025-10-06 | 1,960,591 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer | 2025-10-02 | 2025-10-06 | 43,678 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-10-02 | 2025-10-06 | 189,195 | $0.01 | $1.9K | 788,259 | SEC↗ |
| NEUE NeueHealth, Inc. | F Tax w/h | 2025-10-02 | 2025-10-06 | 280 | $6.75 | $1.9K | 787,979 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-10-02 | 2025-10-06 | 372,255 | $0.01 | $3.7K | 1,160,234 | SEC↗ |
| NEUE NeueHealth, Inc. | F Tax w/h | 2025-10-02 | 2025-10-06 | 551 | $6.75 | $3.7K | 1,159,683 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer | 2025-10-02 | 2025-10-06 | 1,159,683 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-10-02 | 2025-10-06 | 189,195 | $0.01 | $1.9K | 488,982 | SEC↗ |
| NEUE NeueHealth, Inc. | F Tax w/h | 2025-10-02 | 2025-10-06 | 280 | $6.75 | $1.9K | 488,702 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-10-02 | 2025-10-06 | 186,128 | $0.01 | $1.9K | 674,830 | SEC↗ |
| NEUE NeueHealth, Inc. | F Tax w/h | 2025-10-02 | 2025-10-06 | 276 | $6.75 | $1.9K | 674,554 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer | 2025-10-02 | 2025-10-06 | 674,554 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-10-02 | 2025-10-06 | 1,656,789 | $0.01 | $16.6K | 1,656,789 | SEC↗ |
| NEUE NeueHealth, Inc. | F Tax w/h | 2025-10-02 | 2025-10-06 | 2,455 | $6.75 | $16.6K | 1,654,334 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-10-02 | 2025-10-06 | 607,536 | $0.01 | $6.1K | 2,261,870 | SEC↗ |
| NEUE NeueHealth, Inc. | F Tax w/h | 2025-10-02 | 2025-10-06 | 900 | $6.75 | $6.1K | 2,260,970 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-10-02 | 2025-10-06 | 124,085 | $0.01 | $1.2K | 2,385,055 | SEC↗ |
| NEUE NeueHealth, Inc. | F Tax w/h | 2025-10-02 | 2025-10-06 | 182 | $6.75 | $1.2K | 2,384,873 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer | 2025-10-02 | 2025-10-06 | 2,384,873 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-10-02 | 2025-10-06 | 189,195 | $0.01 | $1.9K | 1,527,217 | SEC↗ |
| NEUE NeueHealth, Inc. | D To issuer | 2025-10-02 | 2025-10-06 | 16,443 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2025-05-13 | 2025-05-15 | 10,500 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2025-05-13 | 2025-05-15 | 10,500 | — | $0 | 16,443 | SEC↗ |
| SNTI Senti Biosciences, Inc. | C Conversion deriv | 2025-03-10 | 2025-03-12 | 3,333 | — | $0 | 0 | SEC↗ |
| SNTI Senti Biosciences, Inc. | C Conversion | 2025-03-10 | 2025-03-12 | 3,333,000 | — | $0 | 3,775,615 | SEC↗ |
| MRKR Marker Therapeutics, Inc. | P Buy | 2024-12-23 | 2024-12-23 | 554,250 | $3.20 | $1.77M | 1,625,678 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 61,865 | — | $0 | 185,594 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 61,865 | — | $0 | 185,594 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 185,595 | — | $0 | 556,782 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2024-10-01 | 2024-10-03 | 61,865 | — | $0 | 185,594 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 12,299,854 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion deriv | 2024-09-16 | 2024-09-17 | 25,142,840 | — | $0 | 0 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 2,091,383 | — | $0 | 3,114,486 | SEC↗ |
| MBX MBX Biosciences, Inc. | P Buy | 2024-09-16 | 2024-09-17 | 500,000 | $16.00 | $8.00M | 3,614,486 | SEC↗ |
| MBX MBX Biosciences, Inc. | C Conversion | 2024-09-16 | 2024-09-17 | 1,023,103 | — | $0 | 1,023,103 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2024-05-13 | 2024-05-14 | 10,500 | — | $0 | 10,500 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise deriv | 2024-05-12 | 2024-05-14 | 4,755 | — | $0 | 0 | SEC↗ |
| NEUE NeueHealth, Inc. | M Exercise | 2024-05-12 | 2024-05-14 | 4,755 | — | $0 | 5,943 | SEC↗ |
| KRRO Korro Bio, Inc. | P Buy | 2024-04-22 | 2024-04-24 | 17,857 | $56.00 | $1000.0K | 1,090,793 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2024-04-08 | 2024-04-10 | 123,729 | — | $0 | 123,729 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2024-04-08 | 2024-04-10 | 123,729 | — | $0 | 123,729 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2024-04-08 | 2024-04-10 | 123,729 | — | $0 | 123,729 | SEC↗ |
| NEUE NeueHealth, Inc. | A Award deriv | 2024-04-08 | 2024-04-10 | 371,187 | — | $0 | 371,187 | SEC↗ |
| BHG Bright Health Group Inc. | A Award deriv | 2023-12-19 | 2023-12-21 | 175,525 | — | $0 | 1,656,789 | SEC↗ |
| BHG Bright Health Group Inc. | A Award deriv | 2023-10-31 | 2023-11-02 | 100,606 | — | $0 | 1,481,264 | SEC↗ |
| BHG Bright Health Group Inc. | A Award deriv | 2023-09-15 | 2023-09-19 | 552,263 | — | $0 | 1,380,658 | SEC↗ |
| BHG Bright Health Group Inc. | A Award deriv | 2023-08-11 | 2023-08-15 | 828,395 | — | $0 | 828,395 | SEC↗ |
| BGRY Berkshire Grey, Inc. | D To issuer | 2023-07-20 | 2023-07-24 | 38,183,023 | — | $0 | 0 | SEC↗ |
| SVRA Savara Inc | P Buy | 2023-07-17 | 2023-07-19 | 333,333 | $3.00 | $1000.0K | 24,471,264 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | J Other | 2023-06-13 | 2023-06-15 | 11,348 | — | $0 | 11,348 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | J Other | 2023-06-13 | 2023-06-15 | 2,000,000 | — | $0 | 2,186,243 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | J Other | 2023-06-13 | 2023-06-15 | 30,000 | — | $0 | 30,000 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | J Other | 2023-06-13 | 2023-06-15 | 30,000 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | J Other | 2023-06-13 | 2023-06-15 | 153 | — | $0 | 153 | SEC↗ |
| BHG Bright Health Group Inc. | M Exercise deriv | 2023-05-13 | 2023-05-16 | 95,109 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | M Exercise | 2023-05-13 | 2023-05-16 | 95,109 | — | $0 | 95,109 | SEC↗ |
| BHG Bright Health Group Inc. | A Award deriv | 2023-05-12 | 2023-05-16 | 380,434 | — | $0 | 380,434 | SEC↗ |
| ACLX Arcellx, Inc. | S Sale | 2022-12-21 | 2022-12-22 | 179 | $30.74 | $5.5K | 0 | SEC↗ |
| ACLX Arcellx, Inc. | J Other | 2022-12-20 | 2022-12-22 | 283 | — | $0 | 283 | SEC↗ |
| ACLX Arcellx, Inc. | J Other | 2022-12-20 | 2022-12-22 | 2,000,000 | — | $0 | 4,745,262 | SEC↗ |
| ACLX Arcellx, Inc. | J Other | 2022-12-20 | 2022-12-22 | 179 | — | $0 | 179 | SEC↗ |
| ACLX Arcellx, Inc. | J Other | 2022-12-20 | 2022-12-22 | 30,000 | — | $0 | 0 | SEC↗ |
| ACLX Arcellx, Inc. | J Other | 2022-12-20 | 2022-12-22 | 30,000 | — | $0 | 30,000 | SEC↗ |
| AKUS Akouos, Inc. | U Tender | 2022-11-30 | 2022-12-02 | 4,294,207 | — | $0 | 0 | SEC↗ |
| IONQ IonQ, Inc. | J Other | 2022-11-16 | 2022-11-18 | 1,654 | — | $0 | 1,654 | SEC↗ |
| IONQ IonQ, Inc. | J Other | 2022-11-16 | 2022-11-18 | 11,691,864 | — | $0 | 14,614,829 | SEC↗ |
| IONQ IonQ, Inc. | J Other | 2022-11-16 | 2022-11-18 | 175,378 | — | $0 | 175,378 | SEC↗ |
| IONQ IonQ, Inc. | J Other | 2022-11-16 | 2022-11-18 | 175,378 | — | $0 | 0 | SEC↗ |
| IONQ IonQ, Inc. | J Other | 2022-11-16 | 2022-11-18 | 1,047 | — | $0 | 1,047 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | J Other | 2022-10-19 | 2022-10-21 | 59,294 | — | $0 | 59,294 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | J Other | 2022-10-19 | 2022-10-21 | 3,952,957 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | J Other | 2022-10-19 | 2022-10-21 | 559 | — | $0 | 559 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | J Other | 2022-10-19 | 2022-10-21 | 3,952,957 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | J Other | 2022-10-19 | 2022-10-21 | 59,294 | — | $0 | 0 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | J Other | 2022-10-19 | 2022-10-21 | 354 | — | $0 | 354 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | J Other | 2022-10-19 | 2022-10-21 | 3,952,957 | — | $0 | 3,952,957 | SEC↗ |
| BHG Bright Health Group Inc. | A Award deriv | 2022-10-17 | 2022-10-19 | 100,000 | $1000.00 | $100.00M | 100,000 | SEC↗ |
| BHG Bright Health Group Inc. | A Award deriv | 2022-10-17 | 2022-10-19 | 37,700 | $1000.00 | $37.70M | 37,700 | SEC↗ |
| ACLX Arcellx, Inc. | P Buy | 2022-06-21 | 2022-06-23 | 312,500 | $16.00 | $5.00M | 6,745,262 | SEC↗ |
| IONQ IonQ, Inc. | S Sale | 2022-05-31 | 2022-05-31 | 498,614 | $5.65 | $2.82M | 26,306,693 | SEC↗ |
| IONQ IonQ, Inc. | S Sale | 2022-05-27 | 2022-05-31 | 1,497,733 | $5.93 | $8.88M | 26,805,307 | SEC↗ |
| IONQ IonQ, Inc. | S Sale | 2022-05-26 | 2022-05-31 | 926,619 | $5.80 | $5.37M | 28,303,040 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | S Sale | 2022-05-25 | 2022-05-26 | 4,445,093 | $0.08 | $355.6K | 0 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | S Sale | 2022-05-24 | 2022-05-26 | 5,931,843 | $0.07 | $415.2K | 4,445,093 | SEC↗ |
| BHG Bright Health Group Inc. | A Award deriv | 2022-05-13 | 2022-05-17 | 95,109 | — | $0 | 95,109 | SEC↗ |
| HOOD Robinhood Markets, Inc. | S Sale | 2022-05-03 | 2022-05-04 | 1,952 | $10.06 | $19.6K | 0 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2022-05-02 | 2022-05-04 | 2,028,736 | — | $0 | 2,028,736 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2022-05-02 | 2022-05-04 | 21,794,173 | — | $0 | 21,794,172 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2022-05-02 | 2022-05-04 | 1,952 | — | $0 | 1,952 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2022-05-02 | 2022-05-04 | 3,083 | — | $0 | 6,371 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2022-05-02 | 2022-05-04 | 30,431 | — | $0 | 0 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2022-05-02 | 2022-05-04 | 30,431 | — | $0 | 30,431 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2022-05-02 | 2022-05-04 | 326,913 | — | $0 | 0 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2022-05-02 | 2022-05-04 | 326,913 | — | $0 | 326,913 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy deriv | 2022-04-11 | 2022-04-13 | 3,000,000 | $1.90 | $5.70M | 3,000,000 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2022-04-11 | 2022-04-13 | 948,948 | $1.90 | $1.80M | 948,948 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2022-04-11 | 2022-04-13 | 2,631,578 | $1.90 | $5.00M | 10,421,428 | SEC↗ |
| ACLX Arcellx, Inc. | C Conversion deriv | 2022-02-08 | 2022-02-09 | 698,421 | — | $0 | 0 | SEC↗ |
| ACLX Arcellx, Inc. | C Conversion deriv | 2022-02-08 | 2022-02-09 | 1,732,786 | — | $0 | 0 | SEC↗ |
| ACLX Arcellx, Inc. | C Conversion deriv | 2022-02-08 | 2022-02-09 | 1,545,307 | — | $0 | 0 | SEC↗ |
| ACLX Arcellx, Inc. | C Conversion deriv | 2022-02-08 | 2022-02-09 | 872,915 | — | $0 | 0 | SEC↗ |
| ACLX Arcellx, Inc. | C Conversion | 2022-02-08 | 2022-02-09 | 4,849,429 | — | $0 | 4,849,429 | SEC↗ |
| ACLX Arcellx, Inc. | P Buy | 2022-02-08 | 2022-02-09 | 1,583,333 | $15.00 | $23.75M | 6,432,762 | SEC↗ |
| HOOD Robinhood Markets, Inc. | S Sale | 2022-01-31 | 2022-02-01 | 2,082 | $14.22 | $29.6K | 0 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2022-01-28 | 2022-02-01 | 2,028,736 | — | $0 | 4,057,472 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2022-01-28 | 2022-02-01 | 21,794,173 | — | $0 | 43,588,345 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2022-01-28 | 2022-02-01 | 1,952 | — | $0 | 2,082 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2022-01-28 | 2022-02-01 | 3,288 | — | $0 | 3,288 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2022-01-28 | 2022-02-01 | 52,175 | — | $0 | 0 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2022-01-28 | 2022-02-01 | 30,431 | — | $0 | 52,175 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2022-01-28 | 2022-02-01 | 348,657 | — | $0 | 0 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2022-01-28 | 2022-02-01 | 326,913 | — | $0 | 348,657 | SEC↗ |
| BHG Bright Health Group Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 125,000 | $1000.00 | $125.00M | 125,000 | SEC↗ |
| BHG Bright Health Group Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 75,000 | $1000.00 | $75.00M | 75,000 | SEC↗ |
| MTCR Metacrine, Inc. | S Sale | 2021-12-22 | 2021-12-27 | 288,768 | $1.00 | $288.8K | 2,734,189 | SEC↗ |
| MTCR Metacrine, Inc. | S Sale | 2021-12-22 | 2021-12-27 | 170,932 | $0.91 | $155.5K | 2,563,257 | SEC↗ |
| MTCR Metacrine, Inc. | S Sale | 2021-12-10 | 2021-12-27 | 37,570 | $1.32 | $49.6K | 3,022,957 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2021-11-10 | 2021-11-12 | 724,800 | — | $0 | 65,382,518 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2021-11-10 | 2021-11-12 | 10,872 | — | $0 | 21,744 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2021-11-10 | 2021-11-12 | 724,800 | — | $0 | 6,086,208 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2021-11-10 | 2021-11-12 | 10,872 | — | $0 | 21,744 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2021-10-27 | 2021-10-29 | 10,872 | — | $0 | 10,872 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2021-10-27 | 2021-10-29 | 724,800 | — | $0 | 6,811,008 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2021-10-27 | 2021-10-29 | 10,872 | — | $0 | 10,872 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2021-10-27 | 2021-10-29 | 724,800 | — | $0 | 66,107,318 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy deriv | 2021-10-18 | 2021-10-19 | 1,851,852 | — | $0 | 1,851,852 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy deriv | 2021-10-18 | 2021-10-19 | 1,851,852 | — | $0 | 1,851,852 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2021-10-18 | 2021-10-19 | 1,851,852 | — | $0 | 7,789,850 | SEC↗ |
| HOOD Robinhood Markets, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 55,055,000 | — | $0 | 0 | SEC↗ |
| HOOD Robinhood Markets, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 5,804,240 | — | $0 | 0 | SEC↗ |
| HOOD Robinhood Markets, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 1,449,600 | — | $0 | 0 | SEC↗ |
| HOOD Robinhood Markets, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 1,521,305 | — | $0 | 0 | SEC↗ |
| HOOD Robinhood Markets, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 492,853 | — | $0 | 0 | SEC↗ |
| HOOD Robinhood Markets, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 1,600,000 | — | $0 | 0 | SEC↗ |
| HOOD Robinhood Markets, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 1,449,600 | — | $0 | 0 | SEC↗ |
| HOOD Robinhood Markets, Inc. | C Conversion deriv | 2021-08-02 | 2021-08-03 | 4,486,208 | — | $0 | 0 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2021-08-02 | 2021-08-03 | 65,382,518 | — | $0 | 0 | SEC↗ |
| HOOD Robinhood Markets, Inc. | C Conversion | 2021-08-02 | 2021-08-03 | 1,600,000 | — | $0 | 6,086,208 | SEC↗ |
| HOOD Robinhood Markets, Inc. | C Conversion | 2021-08-02 | 2021-08-03 | 4,486,208 | — | $0 | 4,486,208 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2021-08-02 | 2021-08-03 | 6,086,208 | — | $0 | 0 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2021-08-02 | 2021-08-03 | 65,382,518 | — | $0 | 65,382,518 | SEC↗ |
| HOOD Robinhood Markets, Inc. | J Other | 2021-08-02 | 2021-08-03 | 6,086,208 | — | $0 | 6,086,208 | SEC↗ |
| HOOD Robinhood Markets, Inc. | C Conversion | 2021-08-02 | 2021-08-03 | 1,449,600 | $26.60 | $38.56M | 66,832,118 | SEC↗ |
| HOOD Robinhood Markets, Inc. | C Conversion | 2021-08-02 | 2021-08-03 | 1,449,600 | $26.60 | $38.56M | 7,535,808 | SEC↗ |
| HOOD Robinhood Markets, Inc. | C Conversion | 2021-08-02 | 2021-08-03 | 55,055,000 | — | $0 | 57,564,120 | SEC↗ |
| HOOD Robinhood Markets, Inc. | C Conversion | 2021-08-02 | 2021-08-03 | 5,804,240 | — | $0 | 63,368,360 | SEC↗ |
| HOOD Robinhood Markets, Inc. | C Conversion | 2021-08-02 | 2021-08-03 | 492,853 | — | $0 | 63,861,213 | SEC↗ |
| HOOD Robinhood Markets, Inc. | C Conversion | 2021-08-02 | 2021-08-03 | 1,521,305 | — | $0 | 65,382,518 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 9,588,725 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 11,500,000 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion deriv | 2021-06-28 | 2021-06-30 | 2,361,912 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 1,164,748 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 1,109,284 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 12,712,399 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 4,980,687 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 1,224,428 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 2,448,856 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 15,619,807 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 8,901,166 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 6,516,356 | — | $0 | 0 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion deriv | 2021-06-28 | 2021-06-30 | 1,954,906 | — | $0 | 0 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 3,257,328 | — | $0 | 5,973,296 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 669,002 | — | $0 | 6,642,298 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | P Buy | 2021-06-28 | 2021-06-30 | 1,050,000 | $19.00 | $19.95M | 7,692,298 | SEC↗ |
| GLUE Monte Rosa Therapeutics, I | C Conversion | 2021-06-28 | 2021-06-30 | 2,715,968 | — | $0 | 2,715,968 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 3,327,852 | — | $0 | 107,041,764 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 10,601,925 | — | $0 | 57,461,346 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 26,703,498 | — | $0 | 84,164,844 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 19,549,068 | — | $0 | 103,713,912 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 3,494,244 | — | $0 | 3,494,244 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 5,864,718 | — | $0 | 5,864,718 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 38,137,197 | — | $0 | 44,001,915 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy | 2021-06-28 | 2021-06-30 | 1,694,444 | $18.00 | $30.50M | 23,983,073 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 7,346,568 | — | $0 | 22,288,629 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 14,942,061 | — | $0 | 14,942,061 | SEC↗ |
| BHG Bright Health Group Inc. | P Buy | 2021-06-28 | 2021-06-30 | 250,000 | $18.00 | $4.50M | 47,925,199 | SEC↗ |
| BHG Bright Health Group Inc. | C Conversion | 2021-06-28 | 2021-06-30 | 3,673,284 | — | $0 | 47,675,199 | SEC↗ |
| DM Desktop Metal, Inc. | J Other | 2021-06-08 | 2021-06-10 | 135,000 | — | $0 | 0 | SEC↗ |
| DM Desktop Metal, Inc. | J Other | 2021-06-08 | 2021-06-10 | 806 | — | $0 | 806 | SEC↗ |
| DM Desktop Metal, Inc. | J Other | 2021-06-08 | 2021-06-10 | 1,273 | — | $0 | 1,273 | SEC↗ |
| DM Desktop Metal, Inc. | J Other | 2021-06-08 | 2021-06-10 | 135,000 | — | $0 | 135,000 | SEC↗ |
| DM Desktop Metal, Inc. | J Other | 2021-06-08 | 2021-06-10 | 9,000,000 | — | $0 | 19,263,413 | SEC↗ |
| EAR Eargo, Inc. | S Sale | 2021-05-25 | 2021-05-26 | 283 | $32.41 | $9.2K | 0 | SEC↗ |
| EAR Eargo, Inc. | J Other | 2021-05-24 | 2021-05-26 | 283 | — | $0 | 283 | SEC↗ |
| EAR Eargo, Inc. | J Other | 2021-05-24 | 2021-05-26 | 30,000 | — | $0 | 0 | SEC↗ |
| EAR Eargo, Inc. | J Other | 2021-05-24 | 2021-05-26 | 30,000 | — | $0 | 30,000 | SEC↗ |
| EAR Eargo, Inc. | J Other | 2021-05-24 | 2021-05-26 | 2,000,000 | — | $0 | 4,520,019 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | C Conversion deriv | 2021-04-13 | 2021-04-15 | 8,904,280 | — | $0 | 0 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | C Conversion deriv | 2021-04-13 | 2021-04-15 | 9,526,652 | — | $0 | 0 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | P Buy | 2021-04-13 | 2021-04-15 | 666,666 | $15.00 | $10.00M | 4,785,494 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | C Conversion | 2021-04-13 | 2021-04-15 | 1,989,872 | — | $0 | 4,118,828 | SEC↗ |
| RPHM Reneo Pharmaceuticals, Inc | C Conversion | 2021-04-13 | 2021-04-15 | 2,128,956 | — | $0 | 2,128,956 | SEC↗ |
| MRKR Marker Therapeutics, Inc. | P Buy | 2021-03-16 | 2021-03-18 | 5,714,285 | $1.75 | $10.00M | 10,714,285 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2020-12-04 | 2020-12-07 | 5,239,254 | $0.13 | $681.1K | 5,239,254 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2020-12-04 | 2020-12-07 | 258,707 | $6.22 | $1.61M | 258,707 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2020-12-04 | 2020-12-07 | 4,398,602 | $0.62 | $2.73M | 6,451,056 | SEC↗ |
| EAR Eargo, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-22 | 1,274,929 | — | $0 | 0 | SEC↗ |
| EAR Eargo, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-22 | 546,532 | — | $0 | 0 | SEC↗ |
| EAR Eargo, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-22 | 762,959 | — | $0 | 0 | SEC↗ |
| EAR Eargo, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-22 | 560,789 | — | $0 | 0 | SEC↗ |
| EAR Eargo, Inc. | C Conversion deriv | 2020-10-20 | 2020-10-22 | 1,433,459 | — | $0 | 0 | SEC↗ |
| EAR Eargo, Inc. | C Conversion | 2020-10-20 | 2020-10-22 | 791,214 | — | $0 | 4,076,284 | SEC↗ |
| EAR Eargo, Inc. | C Conversion | 2020-10-20 | 2020-10-22 | 1,433,459 | — | $0 | 6,208,906 | SEC↗ |
| EAR Eargo, Inc. | C Conversion | 2020-10-20 | 2020-10-22 | 699,163 | — | $0 | 4,775,447 | SEC↗ |
| EAR Eargo, Inc. | P Buy | 2020-10-20 | 2020-10-22 | 311,111 | $18.00 | $5.60M | 6,520,017 | SEC↗ |
| EAR Eargo, Inc. | C Conversion | 2020-10-20 | 2020-10-22 | 1,426,354 | — | $0 | 3,285,070 | SEC↗ |
| EAR Eargo, Inc. | C Conversion | 2020-10-20 | 2020-10-22 | 1,858,716 | — | $0 | 1,858,716 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 332,964 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion deriv | 2020-09-18 | 2020-09-22 | 1,958,333 | — | $0 | 0 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 332,964 | — | $0 | 2,291,297 | SEC↗ |
| MTCR Metacrine, Inc. | C Conversion | 2020-09-18 | 2020-09-22 | 1,958,333 | — | $0 | 1,958,333 | SEC↗ |
| MTCR Metacrine, Inc. | P Buy | 2020-09-18 | 2020-09-22 | 769,230 | $13.00 | $10.00M | 3,060,527 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 2,000,533 | — | $0 | 2,000,533 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion | 2020-07-28 | 2020-07-28 | 187,156 | — | $0 | 2,187,689 | SEC↗ |
| INZY Inozyme Pharma, Inc. | P Buy | 2020-07-28 | 2020-07-28 | 250,000 | $16.00 | $4.00M | 2,437,689 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion deriv | 2020-07-25 | 2020-07-28 | 2,000,533 | — | $0 | 0 | SEC↗ |
| INZY Inozyme Pharma, Inc. | C Conversion deriv | 2020-07-25 | 2020-07-28 | 187,156 | — | $0 | 0 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy deriv | 2020-07-24 | 2020-07-28 | 3,151,260 | $0.13 | $409.7K | 3,151,260 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2020-07-24 | 2020-07-28 | 3,151,260 | $2.25 | $7.09M | 10,376,936 | SEC↗ |
| NKTK Nkarta, Inc. | C Conversion deriv | 2020-07-14 | 2020-07-16 | 522,639 | — | $0 | 0 | SEC↗ |
| NKTK Nkarta, Inc. | C Conversion deriv | 2020-07-14 | 2020-07-16 | 1,712,810 | — | $0 | 0 | SEC↗ |
| NKTK Nkarta, Inc. | C Conversion | 2020-07-14 | 2020-07-16 | 522,639 | — | $0 | 522,639 | SEC↗ |
| NKTK Nkarta, Inc. | P Buy | 2020-07-14 | 2020-07-16 | 666,666 | $18.00 | $12.00M | 2,902,115 | SEC↗ |
| NKTK Nkarta, Inc. | C Conversion | 2020-07-14 | 2020-07-16 | 1,712,810 | — | $0 | 2,235,449 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 1,992,238 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 1,199,976 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion deriv | 2020-06-30 | 2020-07-01 | 513,758 | — | $0 | 0 | SEC↗ |
| AKUS Akouos, Inc. | P Buy | 2020-06-30 | 2020-07-01 | 588,235 | $17.00 | $10.00M | 4,294,207 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 1,992,238 | — | $0 | 2,505,996 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 1,199,976 | — | $0 | 3,705,972 | SEC↗ |
| AKUS Akouos, Inc. | C Conversion | 2020-06-30 | 2020-07-01 | 513,758 | — | $0 | 513,758 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS, INC. | P Buy | 2020-06-19 | 2020-06-22 | 1,428,571 | $5.25 | $7.50M | 3,952,958 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | X Exercise deriv | 2020-04-03 | 2020-04-13 | 1,500,000 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | S Sale | 2020-04-03 | 2020-04-13 | 564 | $2.66 | $1.5K | 5,937,998 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | X Exercise | 2020-04-03 | 2020-04-13 | 1,500,000 | — | $0 | 5,938,562 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-12-24 | 2019-12-26 | 900,900 | $6.66 | $6.00M | 900,900 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-12-24 | 2019-12-26 | 9,009,000 | $0.13 | $1.17M | 9,009,000 | SEC↗ |
| ARDX ARDELYX, INC. | A Award | 2019-12-09 | 2019-12-09 | 400,000 | $6.25 | $2.50M | 3,482,186 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion deriv | 2019-07-22 | 2019-07-24 | 29,889,945 | — | $0 | 0 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | P Buy | 2019-07-22 | 2019-07-24 | 450,000 | $15.00 | $6.75M | 4,186,243 | SEC↗ |
| MIRM Mirum Pharmaceuticals, Inc | C Conversion | 2019-07-22 | 2019-07-24 | 3,736,243 | — | $0 | 3,736,243 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2019-06-24 | 2019-06-25 | 2,857,142 | $3.50 | $10.00M | 7,225,676 | SEC↗ |
| NITE Nightstar Therapeutics plc | D To issuer | 2019-06-07 | 2019-06-07 | 6,662,532 | $25.50 | $169.89M | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion deriv | 2019-05-09 | 2019-05-13 | 17,099,315 | — | $0 | 0 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2019-05-09 | 2019-05-13 | 1,500,000 | $10.00 | $15.00M | 4,438,562 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | P Buy | 2019-05-09 | 2019-05-13 | 1,000,000 | $10.00 | $10.00M | 2,938,562 | SEC↗ |
| TRVI Trevi Therapeutics, Inc. | C Conversion | 2019-05-09 | 2019-05-13 | 1,938,562 | — | $0 | 1,938,562 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-05-07 | 2019-05-09 | 3,703,704 | $0.13 | $481.5K | 3,703,704 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy deriv | 2019-05-07 | 2019-05-09 | 256,700 | $10.80 | $2.77M | 256,700 | SEC↗ |
| RGLS Regulus Therapeutics Inc. | P Buy | 2019-05-07 | 2019-05-09 | 1,136,704 | $1.08 | $1.23M | 2,052,454 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy deriv | 2019-04-08 | 2019-04-08 | 4,347,827 | $0.01 | $43.5K | 4,347,827 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2019-04-08 | 2019-04-08 | 4,347,827 | $1.14 | $4.96M | 25,243,865 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy deriv | 2019-02-14 | 2019-02-19 | 2,487,067 | $0.13 | $323.3K | 2,487,067 | SEC↗ |
| GNCA GENOCEA BIOSCIENCES, INC. | P Buy | 2019-02-14 | 2019-02-19 | 9,948,269 | $0.47 | $4.68M | 34,948,269 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-12-21 | 2018-12-21 | 300,000 | $1.49 | $447.0K | 20,896,038 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-12-20 | 2018-12-21 | 200,000 | $1.63 | $326.0K | 20,596,038 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-12-11 | 2018-12-12 | 61,200 | $1.98 | $121.2K | 20,396,038 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-12-10 | 2018-12-10 | 26,000 | $1.98 | $51.5K | 20,334,838 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-12-07 | 2018-12-10 | 117,100 | $1.98 | $231.9K | 20,308,838 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-12-06 | 2018-12-10 | 27,300 | $1.99 | $54.3K | 20,191,738 | SEC↗ |
| AVEO AVEO PHARMACEUTICALS INC | P Buy | 2018-11-30 | 2018-11-30 | 71,900 | $1.98 | $142.4K | 20,164,438 | SEC↗ |